DK2993983T3 - Målretningskorroler til tumortoksicitet og mri - Google Patents
Målretningskorroler til tumortoksicitet og mri Download PDFInfo
- Publication number
- DK2993983T3 DK2993983T3 DK14794410.2T DK14794410T DK2993983T3 DK 2993983 T3 DK2993983 T3 DK 2993983T3 DK 14794410 T DK14794410 T DK 14794410T DK 2993983 T3 DK2993983 T3 DK 2993983T3
- Authority
- DK
- Denmark
- Prior art keywords
- mri
- target directions
- tumor toxicity
- toxicity
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361821106P | 2013-05-08 | 2013-05-08 | |
| PCT/US2014/037234 WO2014182868A1 (en) | 2013-05-08 | 2014-05-08 | Targeting corroles for tumor toxicity and mri |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2993983T3 true DK2993983T3 (da) | 2020-05-18 |
Family
ID=51864925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14794410.2T DK2993983T3 (da) | 2013-05-08 | 2014-05-08 | Målretningskorroler til tumortoksicitet og mri |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9757386B2 (enExample) |
| EP (2) | EP3730155A1 (enExample) |
| JP (1) | JP6640715B2 (enExample) |
| KR (1) | KR20160008523A (enExample) |
| CN (2) | CN108451930A (enExample) |
| AU (2) | AU2014262653B2 (enExample) |
| CA (1) | CA2910030A1 (enExample) |
| DK (1) | DK2993983T3 (enExample) |
| ES (1) | ES2791043T3 (enExample) |
| IL (1) | IL265935B (enExample) |
| MX (1) | MX2015015434A (enExample) |
| PL (1) | PL2993983T3 (enExample) |
| PT (1) | PT2993983T (enExample) |
| RU (1) | RU2674146C2 (enExample) |
| WO (1) | WO2014182868A1 (enExample) |
| ZA (1) | ZA201508092B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9078927B2 (en) | 2007-07-06 | 2015-07-14 | Cedars-Sinai Medical Center | Self-assembling complex for targeting chemical agents to cells |
| WO2010085665A2 (en) | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| KR102115630B1 (ko) | 2012-08-03 | 2020-05-27 | 세다르스-신나이 메디칼 센터 | 약물 전달 단백질의 수송-증진 돌연변이체의 단리 |
| JP6640715B2 (ja) | 2013-05-08 | 2020-02-05 | セダーズ−シナイ メディカル センター | 腫瘍毒性に対する標的コロールおよびｍｒｉ |
| CN106413738B (zh) | 2014-01-17 | 2020-12-29 | 席德-西奈医疗中心 | 受体靶向构造物和其使用 |
| CN106170305A (zh) | 2014-04-04 | 2016-11-30 | 席德-西奈医疗中心 | 用her3靶向纳米粒子靶向曲妥珠单抗抗性her2+乳腺癌 |
| EP3687998A4 (en) * | 2017-08-31 | 2021-05-19 | Technion Research & Development Foundation Limited | CORROL COMPOSITIONS |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA129822A (en) | 1910-08-24 | 1910-12-13 | The John Bertram And Sons Company, Limited | Motor controlling apparatus |
| CA140995A (en) | 1912-03-05 | 1912-06-11 | Davydd C. Hughes | Type plate mechanism |
| US5559099A (en) | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
| WO2002094318A1 (en) | 2001-05-18 | 2002-11-28 | University Of Southern California | Vector for targeted delivery to cells |
| CA2452644C (en) * | 2001-07-02 | 2013-01-22 | Technion Research And Development Foundation Ltd. | Method for the preparation of selectively-substituted corroles and new substituted corroles |
| US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
| US9078927B2 (en) | 2007-07-06 | 2015-07-14 | Cedars-Sinai Medical Center | Self-assembling complex for targeting chemical agents to cells |
| US8791099B2 (en) * | 2007-08-28 | 2014-07-29 | Technion Research And Development Foundation Ltd. | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| US20110098262A1 (en) * | 2008-01-31 | 2011-04-28 | Yondim Moussa B H | Corroles for neuroprotection and neurorescue |
| US8541568B2 (en) | 2008-05-24 | 2013-09-24 | Hai Yan | Compositions and methods using siRNA molecules for treatment of gliomas |
| US9012622B2 (en) | 2008-12-31 | 2015-04-21 | Patrick Y. Lu | Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer |
| WO2010085665A2 (en) | 2009-01-23 | 2010-07-29 | Cedars-Sinai Medical Center | Targeted delivery system |
| CN101704820A (zh) * | 2009-09-24 | 2010-05-12 | 江苏大学 | 三(4-氯苯基)咔咯化合物及其合成方法 |
| WO2011094335A2 (en) | 2010-01-26 | 2011-08-04 | Yale University | Microrna signatures predicting responsiveness to anti-her2 therapy |
| JP2014521738A (ja) * | 2011-08-15 | 2014-08-28 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | コロールおよびスタチンの併用 |
| KR102115630B1 (ko) | 2012-08-03 | 2020-05-27 | 세다르스-신나이 메디칼 센터 | 약물 전달 단백질의 수송-증진 돌연변이체의 단리 |
| JP6640715B2 (ja) | 2013-05-08 | 2020-02-05 | セダーズ−シナイ メディカル センター | 腫瘍毒性に対する標的コロールおよびｍｒｉ |
| CN106413738B (zh) | 2014-01-17 | 2020-12-29 | 席德-西奈医疗中心 | 受体靶向构造物和其使用 |
| CN106170305A (zh) | 2014-04-04 | 2016-11-30 | 席德-西奈医疗中心 | 用her3靶向纳米粒子靶向曲妥珠单抗抗性her2+乳腺癌 |
| AU2017271662A1 (en) | 2016-05-27 | 2018-12-06 | Cedars-Sinai Medical Center | Drug-delivery nanoparticles and treatments for drug-resistant cancer |
-
2014
- 2014-05-08 JP JP2016513057A patent/JP6640715B2/ja not_active Expired - Fee Related
- 2014-05-08 US US14/272,610 patent/US9757386B2/en active Active
- 2014-05-08 CA CA2910030A patent/CA2910030A1/en not_active Abandoned
- 2014-05-08 ES ES14794410T patent/ES2791043T3/es active Active
- 2014-05-08 MX MX2015015434A patent/MX2015015434A/es unknown
- 2014-05-08 CN CN201810246983.5A patent/CN108451930A/zh not_active Withdrawn
- 2014-05-08 PL PL14794410T patent/PL2993983T3/pl unknown
- 2014-05-08 WO PCT/US2014/037234 patent/WO2014182868A1/en not_active Ceased
- 2014-05-08 RU RU2015152033A patent/RU2674146C2/ru active
- 2014-05-08 EP EP20157304.5A patent/EP3730155A1/en not_active Withdrawn
- 2014-05-08 PT PT147944102T patent/PT2993983T/pt unknown
- 2014-05-08 CN CN201480025009.6A patent/CN105307499B/zh not_active Expired - Fee Related
- 2014-05-08 EP EP14794410.2A patent/EP2993983B1/en active Active
- 2014-05-08 KR KR1020157030349A patent/KR20160008523A/ko not_active Ceased
- 2014-05-08 AU AU2014262653A patent/AU2014262653B2/en not_active Ceased
- 2014-05-08 DK DK14794410.2T patent/DK2993983T3/da active
-
2015
- 2015-11-02 ZA ZA2015/08092A patent/ZA201508092B/en unknown
-
2017
- 2017-06-15 US US15/624,228 patent/US10709801B2/en active Active
-
2018
- 2018-10-17 AU AU2018250401A patent/AU2018250401B2/en not_active Ceased
-
2019
- 2019-04-10 IL IL265935A patent/IL265935B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018250401A1 (en) | 2018-11-08 |
| US10709801B2 (en) | 2020-07-14 |
| CA2910030A1 (en) | 2014-11-13 |
| EP2993983A1 (en) | 2016-03-16 |
| CN105307499B (zh) | 2018-04-27 |
| ES2791043T3 (es) | 2020-10-30 |
| PL2993983T3 (pl) | 2020-09-07 |
| PT2993983T (pt) | 2020-05-22 |
| ZA201508092B (en) | 2017-02-22 |
| EP2993983A4 (en) | 2017-01-11 |
| IL265935A (en) | 2019-05-30 |
| WO2014182868A1 (en) | 2014-11-13 |
| AU2014262653A1 (en) | 2015-11-12 |
| KR20160008523A (ko) | 2016-01-22 |
| MX2015015434A (es) | 2016-03-15 |
| CN108451930A (zh) | 2018-08-28 |
| US9757386B2 (en) | 2017-09-12 |
| RU2015152033A (ru) | 2017-06-16 |
| EP2993983B1 (en) | 2020-03-25 |
| AU2014262653B2 (en) | 2018-07-26 |
| CN105307499A (zh) | 2016-02-03 |
| JP2016526021A (ja) | 2016-09-01 |
| HK1221870A1 (en) | 2017-06-16 |
| RU2674146C2 (ru) | 2018-12-07 |
| US20170281802A1 (en) | 2017-10-05 |
| US20140335025A1 (en) | 2014-11-13 |
| AU2018250401B2 (en) | 2020-06-11 |
| RU2015152033A3 (enExample) | 2018-04-25 |
| JP6640715B2 (ja) | 2020-02-05 |
| EP3730155A1 (en) | 2020-10-28 |
| IL265935B (en) | 2020-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3294770T3 (da) | Terapeutiske og diagnostiske fremgangsmåder til cancer | |
| DK2970896T3 (da) | Manipulerede levervæv, arrays deraf og fremgangsmåder til fremstilling heraf | |
| DK3888658T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| DK2956483T3 (da) | Terapeutisk og diagnostisk mål for cancer omfattende dll3-bindende reagenser | |
| DK3052181T3 (da) | Mikronåleplastre og systemer | |
| IL245036B (en) | Pesticidal compositions and related methods | |
| HUE057061T2 (hu) | Kombinációs terápia rák kezelésére | |
| DK3052485T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK3356558T3 (da) | Sirs patogenbiomarkører og anvendelser deraf | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK2970123T3 (da) | Salt af omecamtiv mecarbil og fremgangsmåde til fremstilling heraf | |
| DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3076976T3 (da) | Fremgangsmåder til behandling af cancer | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| EP2967478A4 (en) | ON THE BODY PORTABLE ELECTROMAGNETIC TOMOGRAPHIC IMAGING | |
| DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
| EP2953547A4 (en) | NONLINEAR ECHOGEN MARKERS | |
| HUE060909T2 (hu) | Mûtrágya készítmények | |
| DK3027564T3 (da) | Nedsænket forbrændingssmelter og fremgangsmåde | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
| DE102016117105A8 (de) | Antenneneinrichtung |